• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Dermata Therapeutics, Inc. - Common Stock (NQ:DRMA)

    1.330 +0.250 (+23.15%)
    Streaming Delayed Price Updated: 2:47 PM EDT, Aug 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 15,622,106
    Open 1.260
    Bid (Size) 1.310 (300)
    Ask (Size) 1.330 (1,000)
    Prev. Close 1.080
    Today's Range 1.190 - 1.460
    52wk Range 0.9509 - 6.575
    Shares Outstanding 1,026,457
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Unusual volume stocks are being observed in Wednesday's session. ↗
    Via Chartmill
    The market is filled with gapping stocks in Wednesday's session. ↗
    Via Chartmill

    Performance

    YTD
    -39.0%
    -39.0%
    1 Month
    -1.5%
    -1.5%
    3 Month
    +7.3%
    +7.3%
    6 Month
    -21.3%
    -21.3%
    1 Year
    -78.4%
    -78.4%

    More News

    Read More
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
    From Dermata Therapeutics
    Via ACCESS Newswire
    News headline image
    Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
    From Dermata Therapeutics
    Via ACCESS Newswire
    Dermata Therapeutics (NASDAQ:DRMA) Q1 2026 Earnings: Narrowing Losses and Strategic Pivot to DTC Skincare ↗
    Via Chartmill
    News headline image
    Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
    Via ACCESS Newswire
    News headline image
    Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
    Via ACCESS Newswire
    News headline image
    Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
    Via ACCESS Newswire
    What's going on in today's session ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    Get insights into the top gainers and losers of Thursday's after-hours session. ↗
    Via Chartmill
    News headline image
    Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
    Via ACCESS Newswire
    News headline image
    Dermata Opens a New Chapter with the Release of Tome Skincare
    Via ACCESS Newswire
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Top movers in Friday's session ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    Which stocks are moving before the opening bell on Friday? ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    These stocks are moving in today's session ↗
    Via Chartmill
    Gapping stocks in Thursday's session ↗
    Via Chartmill
    Tuesday's after hours session: top gainers and losers ↗
    Via Chartmill
    Top movers analysis one hour before the close of the markets on 2026-01-26: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Dermata Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Dermata Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Dermata Therapeutics, Inc. - Common Stock trade on?
    Dermata Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Dermata Therapeutics, Inc. - Common Stock?
    The ticker symbol for Dermata Therapeutics, Inc. - Common Stock is DRMA on the Nasdaq Stock Market
    What is the current price of Dermata Therapeutics, Inc. - Common Stock?
    The current price of Dermata Therapeutics, Inc. - Common Stock is 1.330
    When was Dermata Therapeutics, Inc. - Common Stock last traded?
    The last trade of Dermata Therapeutics, Inc. - Common Stock was at 08/12/26 02:47 PM ET
    What is the market capitalization of Dermata Therapeutics, Inc. - Common Stock?
    The market capitalization of Dermata Therapeutics, Inc. - Common Stock is 1.37M
    How many shares of Dermata Therapeutics, Inc. - Common Stock are outstanding?
    Dermata Therapeutics, Inc. - Common Stock has 1M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.